167 related articles for article (PubMed ID: 15086316)
1. Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan.
Kapoor M; Reddy CC; Krishnasastry MV; Surolia N; Surolia A
Biochem J; 2004 Aug; 381(Pt 3):719-24. PubMed ID: 15086316
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum.
Kapoor M; Gopalakrishnapai J; Surolia N; Surolia A
Biochem J; 2004 Aug; 381(Pt 3):735-41. PubMed ID: 15139852
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues.
Sivaraman S; Sullivan TJ; Johnson F; Novichenok P; Cui G; Simmerling C; Tonge PJ
J Med Chem; 2004 Jan; 47(3):509-18. PubMed ID: 14736233
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.
Banerjee T; Sharma SK; Surolia N; Surolia A
Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum.
Suguna K; Surolia A; Surolia N
Biochem Biophys Res Commun; 2001 Apr; 283(1):224-8. PubMed ID: 11322792
[TBL] [Abstract][Full Text] [Related]
6. Kinetic and structural analysis of the increased affinity of enoyl-ACP (acyl-carrier protein) reductase for triclosan in the presence of NAD+.
Kapoor M; Mukhi PL; Surolia N; Suguna K; Surolia A
Biochem J; 2004 Aug; 381(Pt 3):725-33. PubMed ID: 15125687
[TBL] [Abstract][Full Text] [Related]
7. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.
Surolia N; Surolia A
Nat Med; 2001 Feb; 7(2):167-73. PubMed ID: 11175846
[TBL] [Abstract][Full Text] [Related]
8. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors.
Kapoor M; Dar MJ; Surolia A; Surolia N
Biochem Biophys Res Commun; 2001 Dec; 289(4):832-7. PubMed ID: 11735121
[TBL] [Abstract][Full Text] [Related]
9. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
Heath RJ; Su N; Murphy CK; Rock CO
J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
[TBL] [Abstract][Full Text] [Related]
10. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan.
Ward WH; Holdgate GA; Rowsell S; McLean EG; Pauptit RA; Clayton E; Nichols WW; Colls JG; Minshull CA; Jude DA; Mistry A; Timms D; Camble R; Hales NJ; Britton CJ; Taylor IW
Biochemistry; 1999 Sep; 38(38):12514-25. PubMed ID: 10493822
[TBL] [Abstract][Full Text] [Related]
11. Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy.
Surolia N; RamachandraRao SP; Surolia A
Bioessays; 2002 Feb; 24(2):192-6. PubMed ID: 11835284
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis.
Hoang TT; Schweizer HP
J Bacteriol; 1999 Sep; 181(17):5489-97. PubMed ID: 10464225
[TBL] [Abstract][Full Text] [Related]
13. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
Sharma SK; Parasuraman P; Kumar G; Surolia N; Surolia A
J Med Chem; 2007 Feb; 50(4):765-75. PubMed ID: 17263522
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs.
Sivaraman S; Zwahlen J; Bell AF; Hedstrom L; Tonge PJ
Biochemistry; 2003 Apr; 42(15):4406-13. PubMed ID: 12693936
[TBL] [Abstract][Full Text] [Related]
15. Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene.
Marcinkeviciene J; Jiang W; Kopcho LM; Locke G; Luo Y; Copeland RA
Arch Biochem Biophys; 2001 Jun; 390(1):101-8. PubMed ID: 11368521
[TBL] [Abstract][Full Text] [Related]
16. Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase.
Perozzo R; Kuo M; Sidhu Ab; Valiyaveettil JT; Bittman R; Jacobs WR; Fidock DA; Sacchettini JC
J Biol Chem; 2002 Apr; 277(15):13106-14. PubMed ID: 11792710
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of triclosan inhibition of bacterial fatty acid synthesis.
Heath RJ; Rubin JR; Holland DR; Zhang E; Snow ME; Rock CO
J Biol Chem; 1999 Apr; 274(16):11110-4. PubMed ID: 10196195
[TBL] [Abstract][Full Text] [Related]
18. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
Massengo-Tiassé RP; Cronan JE
J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene.
Heath RJ; Li J; Roland GE; Rock CO
J Biol Chem; 2000 Feb; 275(7):4654-9. PubMed ID: 10671494
[TBL] [Abstract][Full Text] [Related]
20. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I.
McLeod R; Muench SP; Rafferty JB; Kyle DE; Mui EJ; Kirisits MJ; Mack DG; Roberts CW; Samuel BU; Lyons RE; Dorris M; Milhous WK; Rice DW
Int J Parasitol; 2001 Feb; 31(2):109-13. PubMed ID: 11239932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]